Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Declares $0.30 Quarterly Dividend

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced a quarterly dividend on Tuesday, February 4th,Wall Street Journal reports. Investors of record on Friday, February 14th will be given a dividend of 0.30 per share by the real estate investment trust on Friday, February 28th. This represents a $1.20 dividend on an annualized basis and a yield of 7.10%. The ex-dividend date of this dividend is Friday, February 14th.

Sabra Health Care REIT has increased its dividend by an average of 24.3% per year over the last three years. Sabra Health Care REIT has a payout ratio of 160.0% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities analysts expect Sabra Health Care REIT to earn $1.45 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 82.8%.

Sabra Health Care REIT Price Performance

SBRA stock traded up $0.17 during mid-day trading on Wednesday, hitting $16.89. 64,959 shares of the stock were exchanged, compared to its average volume of 1,616,075. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. The stock has a market capitalization of $4.00 billion, a price-to-earnings ratio of 41.22, a PEG ratio of 2.01 and a beta of 1.25. The business has a fifty day moving average price of $17.29 and a 200 day moving average price of $17.63. Sabra Health Care REIT has a 12 month low of $12.85 and a 12 month high of $20.03.

Analysts Set New Price Targets

SBRA has been the subject of several analyst reports. Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Scotiabank increased their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research note on Friday, October 11th. Truist Financial cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and dropped their price target for the company from $18.00 to $17.00 in a research report on Friday, January 17th. Mizuho reaffirmed a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a report on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Sabra Health Care REIT has an average rating of “Moderate Buy” and a consensus price target of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.